幽门螺杆菌阴性消化性溃疡并发出血的危险因素分析(3)
 |
| 第1页 |
参见附件(2103KB，3页)。
[2] Howden CW,Leontiadis GI.Current indications for acid suppressants in Helicobacter pylori-negative ulcer disease.Best Pract Res Clin Gastroenterol,2001,15(3):401-412.
[3] Xia HH,Wong BC,Wong KW,et al.Clinical and endoscopic characteristics of non-helicobacter pylori,non-NSAID duodenal ulcers:a long-term prospective study.Aliment Pharmacol Ther,2001,15(12):1875-1882.
[4] Liu NJ,Lee CS,Tang JH,et al.Outcomes of bleeding peptic ulcers:a prospective study.J Gastroenterol Hepatol,2008,23(8 Pt 2):e340-347.
[5] Grinevich VB,Uspenskii IuP,Shabanova GZh,et al.Characteristcs of non-Helicobacter pylori ulcer disease.Ter Arkh,2002,74(2):24-27.
[6] Ramsoekh D,van Leerdam ME,Rauws EA,et al.Outcome of peptic ulcer bleeding,nonsteroidal anti-inflammatory drug use,and Helicobacter pylori infection.Clin Gastroenterol Hepatol,2005,3(9):859-864.
[7] Rodriguez-Hernandez H,Rodriguez-Moran M,Gonzalez JL,et al.Risk factors associated with upper gastrointestinal bleeding and with mortality.Rev Med Inst Mex Seguro Soc,2009,47(2):179-184.
[8] Elitsur Y,Lawrence Z.Non-Helicobacter pylori related duodenal ulcer disease in children.Helicobacter,2001,6(3):239-243.
[9] Gisbert JP,Legido J,Castel I et al.Risk assessment and outpatient management in bleeding peptic ulcer.J Clin Gastroenterol,2006,40(2):129-134.
您现在查看是摘要介绍页，详见PDF附件(2103KB，3页)。